A particular anti-arrhythmia drug provides a targeted treatment for certain forms of atrial fibrillation.
Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
A genetic variant that increases risk for atrial fibrillation also impacts the response to a common therapy for the heart rhythm disorder.
The state of Michael Stanbery’s health was shocking.
A team led by Vanderbilt University investigators has discovered two new genes — both coding for the signaling protein calmodulin — associated with severe early-onset disorders of heart rhythm.
The main antioxidant compound in green tea increases contractile force in isolated heart cells, suggesting it may be useful in heart failure.
Accessibility Tools